COVID-19 and Goodwill Impairment on IFRS and U.S. GAAP

June 2, 2020 | (Online)
Webcast , Countries

Please join Duff & Phelps experts from across the globe in a discussion of how the coronavirus pandemic has affected goodwill impairment testing.

Register Now

Schedule: 11:00 a.m. (Brazil time) / 10:00 a.m. (ET)


  • Background on how the COVID-19 economic environment is impacting goodwill impairment testing
  • Identifying triggering events and deciding whether an impairment test is appropriate
  • Adjusting cash flow projections
  • Selecting discount rate assumptions
  • Addressing stock market price fluctuations and reconciling value conclusions
  • Highlighting similarities and differences between U.S. GAAP and IFRS


  • Eduardo Luque, Managing Director, Irko
  • Greg Franceschi, Managing Director, Valuation Services and Global Head of the Financial Reporting Practice and Office of Professional Practice
  • Carla Nunes, Managing Director, Valuation Digital Solutions and Office of Professional Practice
  • Nicolas Ballian, Managing Director, Valuation Services
  • Alexandre Pierantoni, Managing Director, Corporate Finance

Valuation Services

When companies require an objective and independent assessment of value, they look to Kroll.